195 related articles for article (PubMed ID: 27453459)
1. The role of macrophages in anti-inflammatory activity of antidepressant drugs.
Nazimek K; Strobel S; Bryniarski P; Kozlowski M; Filipczak-Bryniarska I; Bryniarski K
Immunobiology; 2017 Jun; 222(6):823-830. PubMed ID: 27453459
[TBL] [Abstract][Full Text] [Related]
2. Repeatedly administered antidepressant drugs modulate humoral and cellular immune response in mice through action on macrophages.
Nazimek K; Kozlowski M; Bryniarski P; Strobel S; Bryk A; Myszka M; Tyszka A; Kuszmiersz P; Nowakowski J; Filipczak-Bryniarska I
Exp Biol Med (Maywood); 2016 Aug; 241(14):1540-50. PubMed ID: 27053354
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic Strategies for Treatment of Inflammation-related Depression.
Adzic M; Brkic Z; Mitic M; Francija E; Jovicic MJ; Radulovic J; Maric NP
Curr Neuropharmacol; 2018 Jan; 16(2):176-209. PubMed ID: 28847294
[TBL] [Abstract][Full Text] [Related]
4. Current Therapeutic Approaches for Targeting Inflammation in Depression and Cardiovascular Disease.
Zuzarte P; Duong A; Figueira ML; Costa-Vitali A; Scola G
Curr Drug Metab; 2018; 19(8):674-687. PubMed ID: 29512447
[TBL] [Abstract][Full Text] [Related]
5. Macrophages and depression - a misalliance or well-arranged marriage?
Roman A; Kreiner G; Nalepa I
Pharmacol Rep; 2013; 65(6):1663-72. PubMed ID: 24553015
[TBL] [Abstract][Full Text] [Related]
6. The Influence of Antidepressants on the Immune System.
Szałach ŁP; Lisowska KA; Cubała WJ
Arch Immunol Ther Exp (Warsz); 2019 Jun; 67(3):143-151. PubMed ID: 31032529
[TBL] [Abstract][Full Text] [Related]
7. [New studies on the use of antidepressants].
Deniker P; Loo H; Zarifian E
Ann Med Psychol (Paris); 1980 Jan; 138(1):103-13. PubMed ID: 6104461
[TBL] [Abstract][Full Text] [Related]
8. The immune system, depression and the action of antidepressants.
Leonard BE
Prog Neuropsychopharmacol Biol Psychiatry; 2001 May; 25(4):767-80. PubMed ID: 11383977
[TBL] [Abstract][Full Text] [Related]
9. Role of Aspirin and Dexamethasone against Experimentally Induced Depression in Rats.
Bhatt S; Shukla P; Raval J; Goswami S
Basic Clin Pharmacol Toxicol; 2016 Jul; 119(1):10-8. PubMed ID: 26645736
[TBL] [Abstract][Full Text] [Related]
10. Antidepressants on Multiple Sclerosis: A Review of
Stamoula E; Siafis S; Dardalas I; Ainatzoglou A; Matsas A; Athanasiadis T; Sardeli C; Stamoulas K; Papazisis G
Front Immunol; 2021; 12():677879. PubMed ID: 34093579
[TBL] [Abstract][Full Text] [Related]
11. The Impact of Immunological Factors on Depression Treatment - Relation Between Antidepressants and Immunomodulation Agents.
Vojvodic J; Mihajlovic G; Vojvodic P; Radomirovic D; Vojvodic A; Vlaskovic-Jovicevic T; Peric-Hajzler Z; Matovic D; Dimitrijevic S; Sijan G; Roccia MG; Fioranelli M; Lotti T
Open Access Maced J Med Sci; 2019 Sep; 7(18):3064-3069. PubMed ID: 31850124
[TBL] [Abstract][Full Text] [Related]
12. Suppressive immunoregulatory effects of three antidepressants via inhibition of the nuclear factor-κB activation assessed using primary macrophages of carp (Cyprinus carpio).
Qiu W; Wu M; Liu S; Chen B; Pan C; Yang M; Wang KJ
Toxicol Appl Pharmacol; 2017 May; 322():1-8. PubMed ID: 28263824
[TBL] [Abstract][Full Text] [Related]
13. Glia: an important target for anti-inflammatory and antidepressant activity.
Hashioka S; Miyaoka T; Wake R; Furuya M; Horiguchi J
Curr Drug Targets; 2013 Oct; 14(11):1322-8. PubMed ID: 24020976
[TBL] [Abstract][Full Text] [Related]
14. Side effect profile similarities shared between antidepressants and immune-modulators reveal potential novel targets for treating major depressive disorders.
Sun Y; Narayan VA; Wittenberg GM
BMC Pharmacol Toxicol; 2016 Oct; 17(1):47. PubMed ID: 27765060
[TBL] [Abstract][Full Text] [Related]
15. [The research of new antidepressants: present orientations (author's transl)].
Fieve RR
Encephale; 1979; 5(5 Suppl):671-88. PubMed ID: 44869
[TBL] [Abstract][Full Text] [Related]
16. [Inflammatory mechanism of depression and its new strategy for diagnosis and treatment].
Su WJ; Cao ZY; Jiang CL
Sheng Li Xue Bao; 2017 Oct; 69(5):715-722. PubMed ID: 29063119
[TBL] [Abstract][Full Text] [Related]
17. Modulatory Effects of Antidepressant Classes on the Innate and Adaptive Immune System in Depression.
Eyre HA; Lavretsky H; Kartika J; Qassim A; Baune BT
Pharmacopsychiatry; 2016 May; 49(3):85-96. PubMed ID: 26951496
[TBL] [Abstract][Full Text] [Related]
18. Combination therapy with monoamine oxidase inhibitors and other antidepressants or stimulants: strategies for the management of treatment-resistant depression.
Thomas SJ; Shin M; McInnis MG; Bostwick JR
Pharmacotherapy; 2015 Apr; 35(4):433-49. PubMed ID: 25884531
[TBL] [Abstract][Full Text] [Related]
19. Depression after myocardial infarction: TNF-α-induced alterations of the blood-brain barrier and its putative therapeutic implications.
Liu H; Luiten PG; Eisel UL; Dejongste MJ; Schoemaker RG
Neurosci Biobehav Rev; 2013 May; 37(4):561-72. PubMed ID: 23415700
[TBL] [Abstract][Full Text] [Related]
20. New trends in the neurobiology and pharmacology of affective disorders.
Lasoń W; Budziszewska B; Basta-Kaim A; Kubera M; Maes M
Pharmacol Rep; 2013; 65(6):1441-50. PubMed ID: 24552991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
